Arcturus Therapeutics Holdings Inc. 10-Q filing
Filed 2026-05-07 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001193125-26-211943
- Form type
- 10-Q
- CIK
- 0001768224
- Primary document
- https://www.sec.gov/Archives/edgar/data/1768224/000119312526211943/arct-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Arcturus Therapeutics Holdings Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $2.1M | - | - |
| Operating Income | $-28.9M | - | - |
| Net Income | $-27.0M | - | - |
| Eps Basic | -0.95 | - | - |
| Eps Diluted | -0.95 | - | - |
| Cash And Equivalents | $211.4M | - | - |
| Total Assets | $245.4M | - | - |
| Total Liabilities | $54.0M | - | - |
| Shareholders Equity | $191.4M | - | - |
| Operating Cash Flow | $-19.4M | - | - |
| Capital Expenditures | $0 | - | - |